Product Images Renvela
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 5 images provide visual information about the product associated with Renvela NDC 17856-0130 by Atlantic Biologicals Corps, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Label Image - lbl178560130
Renvela® is a medication in the form of a 800mg film-coated tablet containing sevelamer carbonate. The expiration date for one tablet is March 5th, 2017. The manufacturer of this medication is Genzyme, and it was packaged by UDose in Miami, FL. The lot number for the medication is XO0OOXKX and the distributor is Atlantic Biologicals.*
Figure 1 - renvela 01
This appears to be a chemical formula with the symbols NH2, NH, NH, and OH. It is likely related to molecular or organic chemistry. However, without further context or information, it is not possible to determine the specific meaning or application of this text.*
Figure 2 - renvela 02
Figure 3 - renvela 03
This is a graph showing the reduction in serum phosphorus as a percentage of patients for active control and sevelamer hydrochloride with reduction of X. The graph indicates a marked improvement in serum phosphorus in patients treated with sevelamer hydrochloride. The reduction in serum phosphorus is measured in mg/dL.*
Figure 4 - renvela 04
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.